Back to Search
Start Over
Drug-eluting stents are associated with improved outcomes for the treatment of infrainguinal bypass graft stenoses.
- Source :
-
Journal of vascular surgery [J Vasc Surg] 2019 Mar; Vol. 69 (3), pp. 875-882. Date of Electronic Publication: 2018 Nov 26. - Publication Year :
- 2019
-
Abstract
- Background: Existing endovascular therapies for failing infrainguinal bypass grafts are associated with modest patency rates. The use of everolimus drug-eluting stents (eDESs) for endovascular bypass graft revision has not yet been reported. The objective of this study was to describe and to compare clinical outcomes of eDESs vs percutaneous cutting balloons (PCBs) vs percutaneous transluminal angioplasty (PTA) for the treatment of infrainguinal bypass graft stenoses.<br />Methods: A multicenter, single-institution retrospective analysis of patients with infrainguinal bypass graft stenoses treated by endovascular intervention (August 2010-December 2017) was conducted. The primary study outcome was primary patency of the treated lesion. The secondary outcome was limb salvage. Outcomes are described overall and stratified by endovascular treatment modality using Kaplan-Meier curves and log-rank tests.<br />Results: During the 7-year study period, 43 patients with 78 infrainguinal bypass stenoses were treated by endovascular intervention (eDES, 15; PCB, 23; PTA, 40). Mean age was 63.3 ± 1.7 years, 53.5% were male, and 55.8% were black. The majority of patients were diabetic (60.5%) with a history of smoking (74.4%), and nearly all (83.7%) had two or more comorbidities. Half (48.7%) of bypasses treated were femoral-popliteal bypasses, followed by popliteal-distal (25.6%) and femoral-tibial (25.6%) configurations. The location of revision was the proximal anastomosis in 37.2%, midbypass in 25.6%, and distal anastomosis in 37.2%. There were no significant differences in baseline characteristics, bypass configuration, or revision location between treatment groups (P ≥ .19). Technical success for endovascular bypass intervention was 100%. At 2 years after intervention, primary patency was significantly better for patients treated with eDES (81.8%) compared with PCB (54.7%) or PTA (33.2%; log-rank, P = .03). Limb salvage was achieved in 93.6% of patients, including 86.7%, 91.3%, and 97.5% for eDES, PCB, and PTA, respectively (P = .30).<br />Conclusions: This is the first study reporting the results of eDESs for the treatment of infrainguinal bypass graft stenoses. Use of eDESs for endovascular bypass graft revision not only is feasible but may have better primary patency than other endovascular therapies. These data suggest that eDESs may be considered a safe and efficacious endovascular technique in the armamentarium for treatment of infrainguinal bypass graft stenoses.<br /> (Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Aged
Angioplasty, Balloon adverse effects
Female
Graft Occlusion, Vascular etiology
Graft Occlusion, Vascular physiopathology
Humans
Limb Salvage
Male
Middle Aged
Peripheral Arterial Disease physiopathology
Prosthesis Design
Retrospective Studies
Time Factors
Treatment Outcome
Vascular Patency
Angioplasty, Balloon instrumentation
Blood Vessel Prosthesis
Drug-Eluting Stents
Graft Occlusion, Vascular therapy
Lower Extremity blood supply
Peripheral Arterial Disease surgery
Vascular Surgical Procedures adverse effects
Vascular Surgical Procedures instrumentation
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6809
- Volume :
- 69
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of vascular surgery
- Publication Type :
- Academic Journal
- Accession number :
- 30497859
- Full Text :
- https://doi.org/10.1016/j.jvs.2018.08.189